Docket #: S13-149
Neurexin-1alpha knockout mouse model of autism and schizophrenia
Mouse model used to replicate a gene mutation that has been repeatedly observed in autism and schizophrenia patients.
This invention is jointly owned with UT Southerwestern. For licensing information please contact: TechnologyDevelopment@utsouthwestern.edu
Applications
- Can potentially be used for screening for drugs against neuropsychiatric disorders, for validating drug candidates, or for exploring pathogenetic mechanisms involved in neuropsychiatric disorders
Advantages
- Animal models of schizophrenia and autism are notoriously difficult to generate, and this model replicates not only the genetic nature of these conditions, but also mimics some of the symptoms observed in the conditions.
Publications
- PNAS, October 20, 2009, Vol. 106, No. 42 17908-18003
Similar Technologies
-
Monoclonal antibodies against rat NKp30 (rNKp30) S04-250Monoclonal antibodies against rat NKp30 (rNKp30)
-
Selective modulation of anxiety features S13-095Selective modulation of anxiety features
-
Safe and efficient vibrotactile multi-channel stimulation for the treatment of brain disorders S17-270Safe and efficient vibrotactile multi-channel stimulation for the treatment of brain disorders